Mounjaro®
Starting from £179.99/mo
Start journey Learn moreOne Mounjaro pen contains four weekly doses, so a single pen lasts exactly four weeks when used as prescribed. Each pre-filled KwikPen is designed to deliver one subcutaneous injection per week, with four doses loaded at manufacture — no refilling, no reuse. Because Mounjaro is a prescription-only medicine, a prescriber determines the right dose for you before any pen is dispensed. Once you understand the pen's four-dose structure, questions about timing, storage and what to do if something goes wrong become much easier to answer.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes, four doses, four weeks, one pen. Eli Lilly designed the Mounjaro KwikPen so that each pen contains exactly four pre-set doses at the same strength, whether that strength is 2.5 mg, 5 mg, 7.5 mg or any of the higher options in the licensed range. You inject once a week, on the same day each week if possible, and the pen is finished after the fourth injection.
A question our prescribers hear most weeks is whether the pen can stretch further, whether a fifth dose is somehow left in the device. It cannot. The KwikPen's mechanism is set at manufacture; once the fourth dose is delivered, the pen locks. Trying to administer a fifth injection would not produce a dose, and the attempt is wasted effort. You can read more about the general injection process on our Mounjaro injection page.
Practically, this means your treatment calendar should align neatly with monthly supply cycles. If you order your next pen too late, you risk a gap between doses; your prescriber can advise on the best reorder timing based on your individual schedule.
Once you have taken your first injection from a pen, the clock starts on an in-use storage window. The Mounjaro SmPC specifies the exact number of days you may keep an opened pen, and the Mounjaro SmPC on the eMC is the authoritative place to look that up, we deliberately do not state the figure here because storage guidance can be updated, and reading the leaflet that came with your specific pen is the safest habit.
What is straightforward: the in-use window is measured from your first injection, not from when you bought the pen or removed it from the fridge. If you inject on a Monday, the window starts that Monday. Missing a dose does not pause the clock. This is one reason why keeping your injection day consistent matters: it makes the four-week schedule predictable and means you are less likely to find yourself approaching the pen's in-use limit with doses remaining.
For detail on what the in-use storage rules mean day to day, our page on how long an open Mounjaro pen lasts covers the practical implications in full.
Storage is the main variable. Before first use, Mounjaro pens must be kept refrigerated at 2–8°C. Temperature excursions (leaving the pen somewhere warm, or accidentally freezing it) can compromise the medicine inside, meaning a pen may technically contain four doses but not four viable doses. Always check the solution looks clear before each injection; if it appears cloudy, discoloured or contains particles, do not use it.
The NHS medicines page for tirzepatide confirms the importance of correct storage and refers patients to their leaflet for full detail. It is also worth knowing that the fridge door tends to experience more temperature variation than the main compartment, the middle shelf is a more stable home for your pen. Our dedicated page on how long Mounjaro lasts in the fridge goes deeper on the cold-chain practicalities.
Physical damage is the other risk. A pen that has been dropped, has a bent needle, or does not click as expected should not be used. Never attempt to disassemble or repair it. More on this is covered in our guidance on what to do with a broken Mounjaro pen. Replacement options should always be discussed with your prescriber or pharmacy.
No. Whether your prescription is for the lowest strength or the highest, one pen still provides four weekly doses, the total number of injections does not change across the dose range. What changes is the amount of tirzepatide per dose, not the count. The titration schedule, which moves through strengths in steps decided by your prescriber, is covered in more detail on our broader Mounjaro overview page.
If you are curious about cost relative to dose, the Mounjaro pricing page sets out the context around private treatment costs. One thing to keep in mind: a single pen at any dose is a four-week supply, so comparing prices on a per-pen basis is the same as comparing them per month.
If you have further questions (about eligibility, the consultation process, or how supply works) our free consultation is the next step. A GPhC-registered prescriber reviews every application personally, typically the same day it is submitted.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.